# Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection

> **NCT02738697** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 290 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** Adjuvant chemotherapy
- **PROCEDURE:** Follow-up

## Key facts

- **NCT ID:** NCT02738697
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2020-12
- **Final completion:** 2021-12
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02738697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02738697, "Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02738697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*